|
Oral Nutritional Optimization in Total Joint Arthroplasty
RECRUITINGN/ASponsored by NYU Langone Health
Actively Recruiting
PhaseN/A
SponsorNYU Langone Health
Started2021-07-06
Est. completion2026-12-31
Eligibility
Age55 Years+
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →
NCT04210284
Summary
The purpose of this study is to determine the effect on hematological markers of nutritional intervention on nutritionally deficient patients following total joint replacement surgery.
Eligibility
Age: 55 Years+Healthy volunteers accepted
Inclusion Criteria: 1. Patient are current candidates for elective primary total hip and total knee arthroplasty 2. Patients ≥55 years of age but ≤ 95 3. Patients who meet at least one of the following three laboratory criteria for malnutrition: TSerum Albumin: ≤3.5 mg/dl Pre-Albumin: \<15 mg/dl Transferrin: \<200 mg/dl Exclusion Criteria: 1. Previous history of septic arthritis 2. Allergy to oral supplementation 3. Inability to consume oral supplementation 4. Protein malabsorption syndromes 5. Eating disorders 6. End stage renal and hepatic disease 7. Revision surgery, non-elective surgery, hemiarthroplasty, and unicompartmental knee arthroplasty
Conditions2
ArthritisOsteoarthritis
Locations2 sites
New York
1 sitePennsylvania
1 siteRothman Orthopedic Institute
Philadelphia, Pennsylvania, 19107
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorNYU Langone Health
Started2021-07-06
Est. completion2026-12-31
Eligibility
Age55 Years+
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →
NCT04210284